Cryo-Cell Intl Inc (CCEL) 3.4690 $CCEL
Cryo-Cell, Cord Blood Banking Company, Announces Final Results of Its Tender Offer
GlobeNewswire - Thu Jul 30, 12:00PM CDT
Cryo-Cell International, Inc. (the "Company"
(OTCQB:CCEL), the world's first private cord blood bank to separate and store stem cells in 1992, announced today final results of its tender offer to purchase up to 750,000 shares of its common stock at a price of $3.25 per share, which expired at 12:00 midnight, New York City time on Tuesday, July 28, 2015.
Cryo-Cell Reports Fiscal First Quarter 2015 Financial Results
GlobeNewswire - Thu Jul 16, 3:00PM CDT
Cryo-Cell International, Inc. (the "Company" (OTCQB:CCEL), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the second fiscal quarter ended May 31, 2015.
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2015 Financial Results
GlobeNewswire - Wed Apr 15, 8:06AM CDT
Cryo-Cell International, Inc. (OTCQB:CCEL) (the "Company", the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2015.
Cryo Cell increases share buyback to 6M
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 7:01PM CDT
Cryo-Cell International, Inc., Cord Blood Banking Leader, Takes Significant Ownership Stake in Cord Blood America, Inc., and Encourages CBAI Shareholders to Vote Against Upcoming Share Authorization Proposal
GlobeNewswire - Tue Mar 31, 3:00PM CDT
Cryo-Cell International, Inc. ("Cryo-Cell" announces that on March 20, 2015 it filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing its ownership of 9.6% of the issued and outstanding common stock of Cord Blood America, Inc. ("CBAI".
Cryo-Cell Adopts Three-Year Stockholder Rights Plan
GlobeNewswire - Wed Dec 03, 5:30PM CST
Cryo-Cell International, Inc. (OTCQB:CCEL) ("Cryo-Cell" or the "Company", the world's first company to offer cord blood banking services, announced today that its Board of Directors (the "Board" has unanimously adopted a three-year stockholder rights plan (the "Plan", effective December 5, 2014, and declared a dividend distribution of one preferred share purchase right on each outstanding share of the Company's common stock, as well as certain other shares that become outstanding, such as upon the exercise of stock options or conversion or exchange of securities or notes.
Cryo-Cell Q3 revenues up modestly
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 4:12PM CDT
Cryo-Cell Reports Fiscal Third Quarter 2014 Results
GlobeNewswire - Wed Oct 15, 4:25PM CDT
Cryo-Cell International, Inc. (the "Company" (OTCQB:CCEL), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2014.
Cryo-Cell, Cord Blood Banking Company, Announces Final Results of Its Tender Offer
GlobeNewswire - Thu Jul 30, 12:00PM CDT
Cryo-Cell International, Inc. (the "Company"
(OTCQB:CCEL), the world's first private cord blood bank to separate and store stem cells in 1992, announced today final results of its tender offer to purchase up to 750,000 shares of its common stock at a price of $3.25 per share, which expired at 12:00 midnight, New York City time on Tuesday, July 28, 2015. Cryo-Cell Reports Fiscal First Quarter 2015 Financial Results
GlobeNewswire - Thu Jul 16, 3:00PM CDT
Cryo-Cell International, Inc. (the "Company"
(OTCQB:CCEL), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the second fiscal quarter ended May 31, 2015. Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2015 Financial Results
GlobeNewswire - Wed Apr 15, 8:06AM CDT
Cryo-Cell International, Inc. (OTCQB:CCEL) (the "Company"
, the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2015. Cryo Cell increases share buyback to 6M
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 7:01PM CDT
Cryo-Cell International, Inc., Cord Blood Banking Leader, Takes Significant Ownership Stake in Cord Blood America, Inc., and Encourages CBAI Shareholders to Vote Against Upcoming Share Authorization Proposal
GlobeNewswire - Tue Mar 31, 3:00PM CDT
Cryo-Cell International, Inc. ("Cryo-Cell"
announces that on March 20, 2015 it filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing its ownership of 9.6% of the issued and outstanding common stock of Cord Blood America, Inc. ("CBAI". Cryo-Cell Adopts Three-Year Stockholder Rights Plan
GlobeNewswire - Wed Dec 03, 5:30PM CST
Cryo-Cell International, Inc. (OTCQB:CCEL) ("Cryo-Cell" or the "Company"
, the world's first company to offer cord blood banking services, announced today that its Board of Directors (the "Board" has unanimously adopted a three-year stockholder rights plan (the "Plan", effective December 5, 2014, and declared a dividend distribution of one preferred share purchase right on each outstanding share of the Company's common stock, as well as certain other shares that become outstanding, such as upon the exercise of stock options or conversion or exchange of securities or notes. Cryo-Cell Q3 revenues up modestly
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 4:12PM CDT
Cryo-Cell Reports Fiscal Third Quarter 2014 Results
GlobeNewswire - Wed Oct 15, 4:25PM CDT
Cryo-Cell International, Inc. (the "Company"
(OTCQB:CCEL), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2014. 
